Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Operating Expenses | 55,934 | 93,138 | 35,758 | 11,841 | 13,863 |
| Operating Income | -55,934 | -93,138 | -35,758 | -11,841 | -13,863 |
| Interest Expense | 3,354 | 2,803 | 845 | 170 | 0 |
| Other Income | 13,959 | -3,132 | -3,811 | -192 | -4,237 |
| Pre-tax Income | -45,329 | -99,073 | -40,414 | -12,203 | -18,099 |
| Net Income Continuous | -45,329 | -99,073 | -40,414 | -12,203 | -18,099 |
| Net Income | $-45,329 | $-99,073 | $-40,414 | $-12,203 | $-18,099 |
| EPS Basic Total Ops | -50.16 | -169.44 | -112.64 | -515.84 | -862.08 |
| EPS Basic Continuous Ops | -50.19 | -169.46 | -112.90 | -515.85 | -862.24 |
| EPS Diluted Total Ops | -50.16 | -169.44 | -112.64 | -515.84 | -862.08 |
| EPS Diluted Continuous Ops | -50.19 | -169.46 | -112.90 | -515.85 | -862.24 |
| EPS Diluted Before Non-Recurring Items | -65.92 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-54,731 | $-92,236 | $-34,870 | $-11,606 | $-13,841 |